JOP20230043A1 - طرق لعلاج مرض قلبي وعائي باستخدام مركبات سيكلودكسترين - Google Patents

طرق لعلاج مرض قلبي وعائي باستخدام مركبات سيكلودكسترين

Info

Publication number
JOP20230043A1
JOP20230043A1 JOJO/P/2023/0043A JOP20230043A JOP20230043A1 JO P20230043 A1 JOP20230043 A1 JO P20230043A1 JO P20230043 A JOP20230043 A JO P20230043A JO P20230043 A1 JOP20230043 A1 JO P20230043A1
Authority
JO
Jordan
Prior art keywords
disease
effective amount
atherosclerosis
baseline
increase
Prior art date
Application number
JOJO/P/2023/0043A
Other languages
Arabic (ar)
English (en)
Inventor
Jason Camm
Diana Kerwin
Original Assignee
Beren Therapeutics P B C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beren Therapeutics P B C filed Critical Beren Therapeutics P B C
Publication of JOP20230043A1 publication Critical patent/JOP20230043A1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JOJO/P/2023/0043A 2020-08-27 2023-02-27 طرق لعلاج مرض قلبي وعائي باستخدام مركبات سيكلودكسترين JOP20230043A1 (ar)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063071257P 2020-08-27 2020-08-27
PCT/US2021/048084 WO2022047249A1 (en) 2020-08-27 2021-08-27 Methods for the treatment of cardiovascular disease with cyclodextrins

Publications (1)

Publication Number Publication Date
JOP20230043A1 true JOP20230043A1 (ar) 2023-02-27

Family

ID=80353287

Family Applications (1)

Application Number Title Priority Date Filing Date
JOJO/P/2023/0043A JOP20230043A1 (ar) 2020-08-27 2023-02-27 طرق لعلاج مرض قلبي وعائي باستخدام مركبات سيكلودكسترين

Country Status (14)

Country Link
US (2) US20240000826A1 (cg-RX-API-DMAC10.html)
EP (1) EP4203974A4 (cg-RX-API-DMAC10.html)
JP (1) JP2023543131A (cg-RX-API-DMAC10.html)
KR (1) KR20230104119A (cg-RX-API-DMAC10.html)
CN (1) CN116322644A (cg-RX-API-DMAC10.html)
AU (1) AU2021331487A1 (cg-RX-API-DMAC10.html)
CA (1) CA3189915A1 (cg-RX-API-DMAC10.html)
CO (1) CO2023003656A2 (cg-RX-API-DMAC10.html)
CR (1) CR20230135A (cg-RX-API-DMAC10.html)
IL (1) IL300805A (cg-RX-API-DMAC10.html)
JO (1) JOP20230043A1 (cg-RX-API-DMAC10.html)
MX (1) MX2023002418A (cg-RX-API-DMAC10.html)
PE (1) PE20231169A1 (cg-RX-API-DMAC10.html)
WO (1) WO2022047249A1 (cg-RX-API-DMAC10.html)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877778A (en) * 1987-07-01 1989-10-31 The Children's Medical Center Corporation Method of enhancing lipophile transport using cyclodextrin derivatives
WO2013155485A2 (en) * 2012-04-13 2013-10-17 Alessia Fornoni Method of using cyclodextrin

Also Published As

Publication number Publication date
EP4203974A1 (en) 2023-07-05
CA3189915A1 (en) 2022-03-03
IL300805A (en) 2023-04-01
CN116322644A (zh) 2023-06-23
KR20230104119A (ko) 2023-07-07
MX2023002418A (es) 2023-07-11
EP4203974A4 (en) 2024-08-07
JP2023543131A (ja) 2023-10-13
CR20230135A (es) 2023-07-19
CO2023003656A2 (es) 2023-08-09
AU2021331487A1 (en) 2023-03-16
WO2022047249A1 (en) 2022-03-03
US20240000826A1 (en) 2024-01-04
US20230091966A1 (en) 2023-03-23
PE20231169A1 (es) 2023-07-26

Similar Documents

Publication Publication Date Title
CY1125397T1 (el) Αναστολεις προλυλ υδροξυλασης και μεθοδοι χρησης
Tayebjee et al. Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: relationship to disease severity
Osherov et al. Incidence of early left ventricular thrombus after acute anterior wall myocardial infarction in the primary coronary intervention era
NO20071930L (no) t4Metoder og sammensetninger til behandling av hyperlipidemi.
JP2009536218A5 (cg-RX-API-DMAC10.html)
Rutledge et al. Antithrombotic strategies in children receiving long-term Berlin Heart EXCOR ventricular assist device therapy
Jurasz et al. Nonremodeling properties of matrix metalloproteinases: the platelet connection
JOP20230130A1 (ar) أحماض بيرازولو بيبريدين كربوكسيليك تحمل بدائل
JOP20230132A1 (ar) أحماض بيرازولو بيبريدين كربوكسيليك تحمل بدائل
CR20230135A (es) Métodos para el tratamiento de enfermedades cardiovasculares con ciclodextrinas
Kato et al. Internal mammary artery steal in a dialysis patient
Saedi et al. Congenital atresia of left main coronary artery
Hackl et al. COPART risk score predicts long-term mortality in peripheral arterial occlusive disease
Ceyhun et al. Relationship between whole blood viscosity and lesion severity in coronary artery disease
Stolic et al. The influence of atherosclerosis and plasma D-dimer concentration in patients with a functioning arteriovenous fistula for maintenance hemodialysis
Schachner et al. Factors associated with presence of ascending aortic atherosclerosis in CABG patients
Elsayed et al. Evaluation of different surgical modalities for coronary reconstruction of diffusely diseased left anterior descending artery
Rehman et al. Pulmonary hypertension and leading factors in patients undergoing dialysis.
Green et al. The heart in atherosclerotic renovascular disease
Khot et al. From congenital variants to critical clues: A radiologic review of inferior vena cava pathologies
MXPA06009987A (es) Derivados de 4-anilinoquinazolinas con propiedades inhibidoras de adenosina-cinasa.
Akella et al. Coexisting portal vein thrombosis and aortic thrombosis in a patient with COVID-19: A case report and literature review
Gupta et al. Managing patients of shock and acute kidney injury in tertiary care cardiac ICU: Experience with continuous renal replacement therapy
Moore et al. Journal of Critical Limb Ischemia
Shigidi Evaluating the use of tunneled hemodialysis catheters in the treatment of acute kidney disease patients requiring hemodialysis: a case–control study